Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma

Background: Papillary renal cell carcinoma (PRCC), although the second-most common type of renal cell carcinoma, still lacks specific biomarkers for diagnosis, treatment, and prognosis. TopBP1-interacting checkpoint and replication regulator (TICRR) is a DNA replication initiation regulator upregula...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Shuang, Lin, Yan, Lin, Jiaqiong, Li, Xiaoyong, Tan, Xuexian, Huang, Zena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831611/
https://www.ncbi.nlm.nih.gov/pubmed/33505430
http://dx.doi.org/10.3389/fgene.2020.605378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831611/
https://www.ncbi.nlm.nih.gov/pubmed/33505430
http://dx.doi.org/10.3389/fgene.2020.605378

Ejemplares similares